The inflammatory response in acute pancreatitis

Current Opinion in Critical Care

Volumn 4, Issue 2, 1998, Pages 121-124

  Kingsnorth, Andrew ^a   Sargen, Kevin ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000623375     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199804000-00010     Document Type: Article

References (38)

1. Kingsnorth A: Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997, 40:1-4.
2. Davies MG, Hagen P-O: Systemic Inflammatory response syndrome. Br J Surg 1997, 84:920-935.
3. Lemaire LCJM, van Lanschot JJB, Stoutenbeek CP, van Deventer SJH, Wells CL, Gouma DJ: Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg 1997, 84:1340-50. This detailed discussion characterizes MODS into two stages; early MODS, which is a nonbacterial extensive inflammatory response resulting in massive generalized endothelial cell activation, and late MODS, primarily caused by bacterial translocation inducing an imbalance between proinflammatory and anti-inflammatory cytokines. Essential background reading to supplement the paper by Davies and Hagen (Br J Surg 1997, 84:920-935).
4. Lemaire LCJM, van Lanschot JJB, Stoutenbeek CP, van Deventer SJH, Wells CL, Gouma DJ: Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg 1997, 84:1340-50. This detailed discussion characterizes MODS into two stages; early MODS, which is a nonbacterial extensive inflammatory response resulting in massive generalized endothelial cell activation, and late MODS, primarily caused by bacterial translocation inducing an imbalance between proinflammatory and anti-inflammatory cytokines. Essential background reading to supplement the paper by Davies and Hagen (Br J Surg 1997, 84:920-935).
5. Faist E, Schinkel C, Zimmer S: Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996, 20:454-459.
6. Tenner S, Sica G, Hughes M, Noordhock E, Feng S, Zinner M, Banks PA: Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997,113:899-904.
7. Banks PA: Practice guidelines in acute pancreatitis. Am J Gastroenterol 1997, 92:377-386.
8. Hanck C, Rossol S, Gallati H, Singer MV: Enhancement of soluble tumor necrosis factor-α receptors in patients with acute and chronic pancreatitis: association with clinical activity of the disease [abstract]. Digestion 1996, 57:233.
9. Formela LJ, McLaughlin PJ, Flanagan BF, Southern SN, Giles TE, McDicken IF, Kingsnorth AN: Demonstration of tumour necrosis factor in pancreatic acinar cells by in situ hybridisation in a model of acute pancreatitis [abstract]. Gut 1994, 35:575.
10. Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, Pandol SJ: Pancreatic acinar cells produce, release and respond to tumor necrosis factor-α: role in regulating cell death and pancreatitis. J Cell Invest 1997, 100:1853-1862.
11. Sumiyoshi KI, Andoh A, Fujiama Y, Sakumoto H, Bamba T: Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas. J Gastroenterol 1997, 32:367-73.
12. Norman JG, Fink GW, Messina J, Carter G, Franz MG: Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996, 120:515-521.
13. Sargen K, Demaine AG, Kingsnorth AN: Polymorphisms of the tumour necrosis factor β gene in patients with acute pancreatitis [abstract]. Digestion 1997, 58(suppl 2):31.
14. Fink G, Yang J, Carter G, Norman J: Acute pancreatitis - induced enzyme release and necrosis are attenuated by IL-1 antagonism through an indirect mechanism. J Surg Res 1997, 67:94-97.
15. Norman J, Yang J, Fink G, Carter G, Ku G, Denham W, Livingston D: Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res 1997, 17:113-118.
16. Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, Matsuura N, Mori T: Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotising pancreatitis in a rat experimental model. Crit Care Med 1995, 23:901-907.
17. Fisher CJ, Dhainaut JFA, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al. for the phase III rh1L-1ra Sepsis Syndrome Study Group: Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. JAMA 1994, 271:1836-1843.
18. Schreiber S: Interleukin-10 in the intestine. Gut 1997, 41:274-275.
19. van Laethem JC, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J: Interleukin-10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995, 108:1917-1922.
20. Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA: Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996, 120:284-289.
21. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW: Interleukin-10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997, 112:960-967.
22. Pezzilli R, Billi P, Miniero R, Barakat B: Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997, 42:1469-1472.
23. Kingsnorth AN, Galloway SW, Formela U: Randomized, double-blind phase II trial of lexipafant, a platelet-activating factor antagonist in human acute pancreatitis. Br J Surg 1995, 82:1414-1420.
24. Kingsnorth AN for the British Acute Pancreatitis Study Group: Early treatment with lexipafant, a platelet-activating factor antagonist reduces mortality in acute pancreatitis: a double-blind, randomized placebo controlled study [abstract]. Gastroenterology 1997, 112(suppl):A453.
25. Galloway SW, Kingsnorth AN: Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882); a platelet-activating factor antagonist Pancreas 1996, 13:140-146.
26. Emanuelli G, Lupia E, Battaglia E, Dughera L, Buonafede G, Ottone G, Berchio A, Lanfranco G, Priolo G, Doglio R, et al.: Platelet-activating factor (PAF) and cytokine production in human acute pancreatitis [abstract]. Digestion 1997, 58(suppl 2):12.
27. Uomo G, Spada OA, Mares G, Feola B, Misso S, Cavallera A, Rabitti PG: Neopterin in acute pancreatitis. Scand J Gastroenterol 1996, 31:1032-1036.
28. Mora A, Perez-Matio M, Viedma JA, Carballo F, Sanchez-Paya J, Liras G: Activation of cellular immune response in acute pancreatitis. Gut 1997, 40:794-797.
29. Galloway SW, Kingsnorth AN: Changes in lymphocyte subsets in acute pancreatitis [abstract]. Br J Surg 1994, 81:312.
30. Salomone T, Boni P, Serra C, Morselli-Labate AM, Di Gioia AL, Romboli M, Guariento A: The soluble interleukin-2 receptor, peripheral blood and reticulocyte fractions in acute pancreatitis. Int J Pancreatol 1996, 20:197-203.
31. Curley P, Nester M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML: Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology 1996, 110:583-588.
32. Curley P: Endotoxin, cellular immune dysfunction and acute pancreatitis. Ann R Coll Surg Engl 1996, 78:531-535.
33. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nature Med 1997, 3:678-681.
34. Ofrnan J, Koretz RL: Clinical economics review: nutritional support. Aliment Pharmacol Thor 1997, 11:453-471.
35. McClave SA, Greene LM, Snider HL, Makk LJK, Cheadle WG, Owens NA, Dukes LG, Goldsmith LJ: Comparison of the safety of early enterai vs parenteral nutrition in mild acute pancreatitis. JPEN J Parenter Enteral Nutr 1997, 21:14-20.
36. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA: Enterai nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997, 84:1665-1669.
37. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, Steer M: Targeted disruption of the B-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 1997, 100:2022-2027.
38. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, Bottinger BW, Stern DM, Waldherr R, Saegar H-D, et al.: Role of NFκB in mortality of sepsis. J Clin Invest 1997, 100:972-985.